Basic Stats
| LEI | 5493005R8JNDFOLVG764 |
| CIK | 1008586 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Streamline Health Solutions, Inc.
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| August 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 0-28132 Streamline Health Solutions, Inc. (Exact name of registrant as speci |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 14, 2025 |
As filed with the Securities and Exchange Commission on August 14, 2025 As filed with the Securities and Exchange Commission on August 14, 2025 Registration No. |
|
| August 13, 2025 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION STREAMLINE HEALTH SOLUTIONS, INC. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF STREAMLINE HEALTH SOLUTIONS, INC. FIRST: The name of this corporation shall be: Streamline Health Solutions, Inc. SECOND: Its registered office in the State of Delaware is to be located at c/o Corporation Service Company, 251 Little Falls Drive, in the City of Wilmington, County of New Castle, 19808, and its registered agent at such |
|
| August 13, 2025 |
-01-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 12, 2025 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporati |
|
| August 13, 2025 |
MDaudit Finalizes Acquisition of Streamline Health Exhibit 99.1 FOR IMMEDIATE RELEASE MDaudit Finalizes Acquisition of Streamline Health Wellesley, MA – August 12, 2025 – MDaudit, an award-winning cloud-based continuous risk monitoring platform for RCM that enables the nation’s premier healthcare organizations to minimize billing risks and maximize revenues, has finalized its acquisition of Streamline Health Solutions, Inc., a leading provider of |
|
| August 13, 2025 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF STREAMLINE HEALTH SOLUTIONS, INC. A Delaware Corporation Effective August 12, 2025 TABLE OF CONTENTS Page Article I Name and Purpose Section 1.01 Name 1 Section 1.02 Purpose 1 Article II Offices Section 2.01 Registered Office 1 Section 2.02 Other Offices 1 Article III STOCKHOLDERS Section 3.01 Place of Meetings 1 Section 3.02 Annual Meeting 1 Section 3.03 |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Com |
|
| July 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| July 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2025 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Comm |
|
| July 1, 2025 |
SEVENTH MODIFICATION SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT Exhibit 10.1 SEVENTH MODIFICATION TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS SEVENTH MODIFICATION TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Modification”) is entered into as of June 26, 2025 by and among STREAMLINE HEALTH SOLUTIONS, INC., a Delaware corporation (“Streamline”), STREAMLINE HEALTH, LLC, a Delaware limited liability company (f/k/a STREAMLIN |
|
| June 30, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Schedule 14A (Form Type) Streamline Health Solutions, Inc. |
|
| June 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| June 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2025 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Comm |
|
| June 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| June 16, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2025 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Comm |
|
| June 16, 2025 |
Exhibit 99.1 Streamline Health® Reports Fiscal First Quarter 2025 Financial Results Atlanta, GA, June 16, 2025 (Globe Newswire) – Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the fiscal |
|
| June 16, 2025 |
Press release, dated June 16, 2025, regarding First Quarter Fiscal 2025 Financial Results. Exhibit 99.1 Streamline Health® Reports Fiscal First Quarter 2025 Financial Results Atlanta, GA, June 16, 2025 (Globe Newswire) – Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the fiscal |
|
| May 30, 2025 |
Exhibit 10.2(c) INCENTIVE STOCK OPTION AWARD AGREEMENT PURSUANT TO THE STREAMLINE HEALTH SOLUTIONS, INC. 2024 OMNIBUS INCENTIVE COMPENSATION PLAN * * * * * Grantee: Grant Date: Per Share Exercise Price: $ Number of Shares subject to this Option: * * * * * THIS INCENTIVE STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Strea |
|
| May 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K/A (Amendment No. 2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K/A (Amendment No. |
|
| May 30, 2025 |
Exhibit 10.2(b) RESTRICTED STOCK UNIT AWARD AGREEMENT PURSUANT TO THE STREAMLINE HEALTH SOLUTIONS, INC. 2024 OMNIBUS INCENTIVE COMPENSATION PLAN * * * * * Grantee: Grant Date: Number of Restricted Stock Units Granted: * * * * * THIS RESTRICTED STOCK UNIT AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Streamline Health Solutions, Inc., |
|
| May 30, 2025 |
Exhibit 10.2(d) NON-QUALIFIED STOCK OPTION AWARD AGREEMENT PURSUANT TO THE STREAMLINE HEALTH SOLUTIONS, INC. 2024 OMNIBUS INCENTIVE COMPENSATION PLAN Grantee: Grant Date: Per Share Exercise Price: $ Number of Shares subject to this Option: THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Streamline Health |
|
| May 30, 2025 |
Exhibit 10.2(a) RESTRICTED STOCK AWARD AGREEMENT PURSUANT TO THE STREAMLINE HEALTH SOLUTIONS, INC. 2024 OMNIBUS INCENTIVE COMPENSATION PLAN * * * * * Grantee: Grant Date: Number of Shares of Restricted Stock Granted: * * * * * THIS RESTRICTED STOCK AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Streamline Health Solutions, Inc., a Del |
|
| May 29, 2025 |
Exhibit 10.2 AMENDED AND RESTATED MASTER SERVICES AND NON-DISCLOSURE AGREEMENT THIS AMENDED AND RESTATED MASTER SERVICES AND NON-DISCLOSURE AGREEMENT (this “Agreement”), effective as of May 29, 2025 (the “Effective Date”), is made by and between Streamline Health Solutions, Inc., a Delaware corporation (“Company”), with its principle place of business at 1175 Peachtree Street NE, 10th Floor, Atlan |
|
| May 29, 2025 |
Exhibit 10.1 VOTING AND SUPPORT AGREEMENT This Voting and Support Agreement (this “Agreement”) is made and entered into as of May 29, 2025, by and among Mist Holding Co., a Delaware corporation (“Parent”), and the stockholders of Streamline Health Solutions, Inc., a Delaware corporation (the “Company”), set forth on Schedule A hereto (each, a “Stockholder” and, collectively, the “Stockholders”). P |
|
| May 29, 2025 |
MDaudit and Streamline Health Announce Definitive Merger Agreement Exhibit 99.1 MDaudit and Streamline Health Announce Definitive Merger Agreement The combined entity supports healthcare organizations nationwide with an aggregate Net Patient Revenue of more than $300B and brings together best-in-class billing compliance and revenue integrity solutions to empower health systems with actionable foresight and end-to-end visibility. MDaudit to acquire all outstanding |
|
| May 29, 2025 |
Exhibit 10.1 VOTING AND SUPPORT AGREEMENT This Voting and Support Agreement (this “Agreement”) is made and entered into as of May 29, 2025, by and among Mist Holding Co., a Delaware corporation (“Parent”), and the stockholders of Streamline Health Solutions, Inc., a Delaware corporation (the “Company”), set forth on Schedule A hereto (each, a “Stockholder” and, collectively, the “Stockholders”). P |
|
| May 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2025 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Commi |
|
| May 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2025 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Commi |
|
| May 29, 2025 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among MIST HOLDING CO., MD BE MERGER SUB, INC. and STREAMLINE HEALTH SOLUTIONS, INC. Dated as of May 29, 2025 TABLE OF CONTENTS Page ARTICLE I THE MERGER; CLOSING; EFFECTIVE TIME 2 1.1. The Merger 2 1.2. Closing 2 1.3. Effective Time 2 ARTICLE II ORGANIZATIONAL DOCUMENTS OF THE SURVIVING CORPORATION 2 2.1. Certificate of Incorporation of the Survivin |
|
| May 29, 2025 |
Exhibit 10.2 AMENDED AND RESTATED MASTER SERVICES AND NON-DISCLOSURE AGREEMENT THIS AMENDED AND RESTATED MASTER SERVICES AND NON-DISCLOSURE AGREEMENT (this “Agreement”), effective as of May 29, 2025 (the “Effective Date”), is made by and between Streamline Health Solutions, Inc., a Delaware corporation (“Company”), with its principle place of business at 1175 Peachtree Street NE, 10th Floor, Atlan |
|
| May 29, 2025 |
Streamline Health Solutions, Inc. Press Release, dated May 29, 2025. Exhibit 99.1 MDaudit and Streamline Health Announce Definitive Merger Agreement The combined entity supports healthcare organizations nationwide with an aggregate Net Patient Revenue of more than $300B and brings together best-in-class billing compliance and revenue integrity solutions to empower health systems with actionable foresight and end-to-end visibility. MDaudit to acquire all outstanding |
|
| May 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| May 29, 2025 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among MIST HOLDING CO., MD BE MERGER SUB, INC. and STREAMLINE HEALTH SOLUTIONS, INC. Dated as of May 29, 2025 TABLE OF CONTENTS Page ARTICLE I THE MERGER; CLOSING; EFFECTIVE TIME 2 1.1. The Merger 2 1.2. Closing 2 1.3. Effective Time 2 ARTICLE II ORGANIZATIONAL DOCUMENTS OF THE SURVIVING CORPORATION 2 2.1. Certificate of Incorporation of the Survivin |
|
| May 27, 2025 |
Streamline Health Solutions, Inc. Clawback Policy. Exhibit 97 STREAMLINE HEALTH SOLUTIONS, INC. CLAWBACK POLICY The Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of Streamline Health Solutions, Inc., a Delaware corporation (the “Company”) has adopted the following Clawback Policy (this “Policy”) on November 13, 2023, effective as of October 2, 2023 (the “Effective Date”). 1. Purpose. The purpose of t |
|
| May 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K/A (Amendment No. |
|
| May 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING COMMISSION FILE NUMBER: 0-28132 (Check one): ☒Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: January 31, 2025 ☐Transition Report on Form 10-K ☐Transition Report on Form 20-F ☐Transition Report on Form 11-K ☐Transition Report on Form |
|
| May 2, 2025 |
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Streamline Health Solutions, Inc. (the "Company," "we," "our," and "us") has authority to issue 90,000,000 shares of all classes of stock, consisting of 85,000,000 shares of common stock, par value $0.01 per share (the "Common Stock"), and 5,000,000 shares of preferred st |
|
| May 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| May 2, 2025 |
Subsidiaries of Streamline Health Solutions, Inc. Exhibit 21.1 STREAMLINE HEALTH SOLUTIONS, INC. SUBSIDIARIES OF STREAMLINE HEALTH SOLUTIONS, INC. Name Jurisdiction of Incorporation % Owned Streamline Health, LLC Delaware 100 % Avelead Consulting, LLC Delaware 100 % Streamline Consulting Solutions, LLC Delaware 100 % Streamline Pay & Benefits, LLC Delaware 100 % |
|
| May 2, 2025 |
Streamline Health Solutions, Inc. Insider Trading Policy Exhibit 19 INSIDER TRADING POLICY Streamline Health Solutions, Inc. I. Introduction The purpose of this Insider Trading Policy (this “Policy”) is to provide general procedural guidelines for directors, officers, and associates to follow when in possession of Material Nonpublic Information about Streamline Health Solutions, Inc. (the “Company”) or other entities. To avoid the appearance of Trading |
|
| May 1, 2025 |
Exhibit 99.1 Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results Atlanta, GA, May 1, 2025 (Globe Newswire) – Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results fo |
|
| May 1, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2025 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Commis |
|
| March 28, 2025 |
Exhibit 10.1 SIXTH MODIFICATION AND WAIVER TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS SIXTH MODIFICATION AND WAIVER TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Modification”) is entered into as of March 27, 2025 by and among STREAMLINE HEALTH SOLUTIONS, INC., a Delaware corporation (“Streamline”), STREAMLINE HEALTH, LLC, a Delaware limited liability compa |
|
| March 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Com |
|
| December 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| December 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-28132 CUSIP NUMBER: 86323X205 (Check one): ☐Form 10-K ☐Form 20-F ☐Form 11-K ☒Form 10-Q ☐Form 10-D ☐Form N-CEN ☐Form N-CSR For Period Ended: October 31, 2024 ☐Transition Report on Form 10-K ☐Transition Report on Form 20-F ☐Transition Report on Form 11-K ☐Transition Re |
|
| December 16, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2024 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| December 16, 2024 |
Exhibit 99.1 Streamline Health® Reports Fiscal Third Quarter 2024 Financial Results, Accelerates Anticipated Adjusted EBITDA Breakeven Timeline ● Net loss of ($2.5 million) during the third quarter of fiscal 2024 compared to a net loss of ($11.9 million) during the third quarter of fiscal 2023 ● Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectation ● |
|
| November 15, 2024 |
Exhibit 10.1 CERTAIN IDENTIFIED INFORMATION HAS BEEN REDACTED FROM THIS EXHIBIT, BECAUSE IT IS (1) NOT MATERIAL AND (2) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. “[***]” INDICATES THAT INFORMATION HAS BEEN REDACTED. FIFTH MODIFICATION TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS FIFTH MODIFICATION TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT ( |
|
| November 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2024 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| September 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2024 -01-31 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorpor |
|
| September 26, 2024 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF STREAMLINE HEALTH SOLUTIONS, INC. STREAMLINE HEALTH SOLUTIONS, INC., a Delaware corporation (the “Corporation”), does hereby certify that: FIRST: The Certificate of Incorporation, as filed with the Secretary of State of the Delaware on February 7, 1996, and subsequently amended on June 26, 2006, August 19, 2014, and May 24, 20 |
|
| September 26, 2024 |
Exhibit 99.1 Streamline Health® Announces 1-For-15 Reverse Stock Split Atlanta, GA – September 26, 2024 – Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, today announced that it will proceed with a 1-for-15 reverse stock split (the “Reverse Stock Split”) of its outst |
|
| September 19, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2024 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) |
|
| September 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| September 11, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2024 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) |
|
| September 11, 2024 |
Exhibit 99.1 Streamline Health® Reports Fiscal Second Quarter 2024 Financial Results ● Net loss of ($2.8 million) during the second quarter of fiscal 2024 compared to a net loss of ($2.5 million) during the second quarter of fiscal 2023 ● Adjusted EBITDA improved to a loss of ($0.3 million) for the second quarter of fiscal 2024 compared to a loss of ($0.9 million) for the second quarter of fiscal |
|
| August 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| August 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| June 24, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Streamline Health Solutions, Inc. |
|
| June 24, 2024 |
As filed with the U.S. Securities and Exchange Commission on June 24, 2024 As filed with the U.S. Securities and Exchange Commission on June 24, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 31-1455414 (State or other jurisdiction of (I.R.S. Employer incorporat |
|
| June 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2024 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Comm |
|
| June 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| June 12, 2024 |
Exhibit 10.4 FOURTH MODIFICATION TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS FOURTH MODIFICATION TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Modification”) is entered into as of April 5, 2024 by and among STREAMLINE HEALTH SOLUTIONS, INC., a Delaware corporation (“Streamline”), STREAMLINE HEALTH, LLC, a Delaware limited liability company (f/k/a STREAMLINE |
|
| June 11, 2024 |
Exhibit 99.1 Streamline Health® Reports Fiscal First Quarter 2024 Financial Results ● Net loss of ($2.7 million) during the first quarter of fiscal 2024 compared to net loss of ($2.9 million) during the first quarter of fiscal 2023 ● Adjusted EBITDA improved to a loss of ($0.7 million) during the first quarter of fiscal 2024 vs. a loss of ($1.3 million) during the first quarter of fiscal 2023 ● $1 |
|
| June 11, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2024 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Comm |
|
| June 6, 2024 |
Streamline Health Solutions, Inc. 2400 Old Milton Pkwy., Box 1353 Alpharetta, Georgia 30009 Streamline Health Solutions, Inc. 2400 Old Milton Pkwy., Box 1353 Alpharetta, Georgia 30009 June 6, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, NE Washington, D.C. 20549 Attn: Marion Graham; Matthew Crispino Re: Streamline Health Solutions, Inc. Registration Statement on Form S-3 Filed May 7, 2024 File No. 333-2 |
|
| May 24, 2024 |
As filed with the U.S. Securities and Exchange Commission on May 24, 2024 As filed with the U.S. Securities and Exchange Commission on May 24, 2024 Registration No. 333-279190 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Pre-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 31-1455414 (State or other jur |
|
| May 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| May 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Commis |
|
| May 13, 2024 |
Exhibit 10.1 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT This SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (the “Second Amendment”) is entered as of May 7th, 2024, by and between Streamline Health Solutions, Inc., a Delaware corporation with its headquarters in Alpharetta, Georgia (the “Company”), and Wyche T. “Tee” Green, III, a resident of the state of Georgia (“Executive”). This Second Amendment is of |
|
| May 7, 2024 |
As filed with the U.S. Securities and Exchange Commission on May 7, 2024 As filed with the U.S. Securities and Exchange Commission on May 7, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 31-1455414 (State or other jurisdiction of incorporation or organizati |
|
| May 7, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Streamline Health Solutions, Inc. |
|
| April 30, 2024 |
Employment Agreement, dated February 15, 2022, by and between the Company and Benjamin L. Stilwill. Exhibit 10.5 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (together with Exhibit A attached hereto, the “Agreement”) is entered as of February 15, 2022, by and between Streamline Health, LLC, a Delaware limited liability company with its headquarters in Alpharetta, Georgia (the “Company”), and Ben Stilwill, a resident of the state of Pennsylvania (“Executive”). RECITALS: WHEREAS, the Company is |
|
| April 30, 2024 |
Subsidiaries of Streamline Health Solutions, Inc. Exhibit 21.1 STREAMLINE HEALTH SOLUTIONS, INC. SUBSIDIARIES OF STREAMLINE HEALTH SOLUTIONS, INC. Name Jurisdiction of Incorporation % Owned Streamline Health, LLC Delaware 100 % Avelead Consulting, LLC Delaware 100 % Streamline Consulting Solutions, LLC Delaware 100 % Streamline Pay & Benefits, LLC Delaware 100 % |
|
| April 30, 2024 |
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Streamline Health Solutions, Inc. (the “Company,” “we,” “our,” and “us”) has authority to issue 90,000,000 shares of all classes of stock, consisting of 85,000,000 shares of common stock, par value $0.01 per share (the “Common Stock”), and 5,000,000 shares of preferred st |
|
| April 30, 2024 |
Employment Agreement, dated February 4, 2021, by and between the Company and Wendy L. Lovvorn. Exhibit 10.7 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (together with Exhibit A, the “Agreement”) is entered as of February 4, 2021, by and between Streamline Health Solutions, Inc., a Delaware corporation with its headquarters in Atlanta, Georgia (the “Company”), and Wendy Lucio, a resident of the state of Georgia (“Executive”). RECITALS: WHEREAS, the Company and Executive hereby agree that |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| April 29, 2024 |
Exhibit 99.1 Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results ● 14% growth of SaaS revenue in fiscal 2023 compared to fiscal 2022 ● $0.4 million of adjusted EBITDA generated in the fourth quarter of fiscal 2023 compared to ($0.2 million) during the fourth quarter of fiscal 2022; $2.4 million of adjusted EBITDA improvement in fiscal 2023 vs. fiscal 2022 ● ($1.4 |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2024 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Com |
|
| February 7, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of February 1, 2024, by and among Streamline Health Solutions, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). Certain capitalized terms |
|
| February 7, 2024 |
Exhibit 4.1 THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REG |
|
| February 7, 2024 |
Streamline Health® Improves Liquidity Position and Appoints New Directors Exhibit 99.1 Streamline Health® Improves Liquidity Position and Appoints New Directors Streamline expects $4.5 million of additional liquidity will enable achievement of previously announced adjusted EBITDA breakeven of $15.5 million of installed SaaS ARR during the second half of fiscal 2024 ● Expanded board of directors with appointment of CEO Benjamin Stilwill and Matthew Etheridge ● Closed pri |
|
| February 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2024 Streamline Health Solutions, Inc. |
|
| February 7, 2024 |
Exhibit 10.3 THIRD MODIFICATION AND WAIVER TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS THIRD MODIFICATION TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Modification”) is entered into as of February 7, 2024 by and among STREAMLINE HEALTH SOLUTIONS, INC., a Delaware corporation (“Streamline”), STREAMLINE HEALTH, LLC, a Delaware limited liability company (f/k/a |
|
| February 7, 2024 |
Exhibit 10.2 The rights of the holder of this instrument to receive payment hereunder and other rights of the holder of this instrument are subject and subordinate to the rights of the Senior CREDITOR (as defined in the Subordination Agreement DEFINED BELOW) pursuant to the terms of a Subordination Agreement, DATED AS OF THE DATE HEREOF (THE “SUBORDINATION aGREEMENT”), among WESTERN ALLIANCE BANK, |
|
| December 14, 2023 |
Employment Agreement, dated December 4, 2023, by and between Company and Bryant James Reeves Exhibit 10.2 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (together with Exhibit A attached hereto, the “Agreement”) is entered as of December 4th, 2023, by and between Streamline Health, LLC, a Delaware limited liability company with its headquarters in Alpharetta, Georgia (the “Company”), and Bryant James Reeves, a resident of the state of Georgia (“Executive”). RECITALS: WHEREAS, the Company |
|
| December 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| December 14, 2023 |
Exhibit 99.1 Streamline Health® Reports Fiscal Third Quarter 2023 Financial Results ● 22% growth of SaaS revenue in the third quarter of fiscal 2023 compared to the third quarter of fiscal 2022 ● $400 thousand of Adjusted EBITDA generated in the third quarter of fiscal 2023 compared to ($1.2) million during the third quarter of fiscal 2022 ● $13.0 million of Booked SaaS ACV as of October 31, 2023; |
|
| December 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2023 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| December 14, 2023 |
Streamline Health® Announces Signing of new RevID™ Contract with 2,300-Bed Health System Exhibit 99.2 Streamline Health® Announces Signing of new RevID™ Contract with 2,300-Bed Health System 2,300-bed, Maryland-based health system to leverage RevID’s automated charge reconciliation for improved financial performance Atlanta, GA – December 13, 2023 – Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial p |
|
| December 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2023 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (C |
|
| December 7, 2023 |
Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (together with Exhibit A attached hereto, the “Agreement”) is entered as of December 4th, 2023, by and between Streamline Health, LLC, a Delaware limited liability company with its headquarters in Alpharetta, Georgia (the “Company”), and Bryant James Reeves, a resident of the state of Georgia (“Executive”). RECITALS: WHEREAS, the Company |
|
| October 27, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2023 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (C |
|
| October 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2023 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (C |
|
| October 16, 2023 |
General Release, dated October 13, 2023, by and between the Company and Thomas J. Gibson. Exhibit 10.1 |
|
| October 16, 2023 |
Exhibit 99.1 Streamline Health® Executes Strategic Restructuring, Provides Corporate Update ● Executing strategic restructuring to reduce operating expenses and drive profitable growth of SaaS business; estimated annualized cost savings of approximately $5.8 million ● Received termination notice from legacy client with a $4.5M annualized revenue run rate ● Benjamin Stilwill appointed Chief Executi |
|
| September 27, 2023 |
STRM / Streamline Health Solutions, Inc / GCI Partners Opportunity Fund, LP Passive Investment SC 13G 1 r926230sc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Streamline Health Solutions Inc. (Name of Issuer) Common Stock, par value $0.01 (Title of Class of Securities) 86323X106 (CUSIP Number) September 26, 2023 (Date of Event Which Requires Filing of This Statement) Check the appropri |
|
| September 14, 2023 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2023 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) |
|
| September 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| September 14, 2023 |
Exhibit 99.1 Streamline Health® Reports Fiscal Second Quarter Financial Results 13% growth of SaaS revenue in the first half of fiscal 2023 compared to the first half of fiscal 2022 Atlanta, GA, September 13, 2023 (Globe Newswire) – Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively addre |
|
| July 6, 2023 |
Streamline Health Solutions, Inc. 2400 Old Milton Pkwy., Box 1353 Alpharetta, Georgia 30009 Streamline Health Solutions, Inc. 2400 Old Milton Pkwy., Box 1353 Alpharetta, Georgia 30009 July 6, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attn: Marion Graham, Staff Attorney Matthew Derby, Legal Branch Chief Re: Streamline Health Solutions, Inc. Registration Statement on Form S-3 Filed June 28, 2023 F |
|
| June 28, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Streamline Health Solutions, Inc. |
|
| June 28, 2023 |
As filed with the U.S. Securities and Exchange Commission on June 28, 2023 As filed with the U.S. Securities and Exchange Commission on June 28, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 31-1455414 (State or other jurisdiction of incorporation or organiza |
|
| June 28, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Streamline Health Solutions, Inc. |
|
| June 28, 2023 |
As filed with the U.S. Securities and Exchange Commission on June 28, 2023 As filed with the U.S. Securities and Exchange Commission on June 28, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 31-1455414 (State or other jurisdiction of (I.R.S. Employer incorporat |
|
| June 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2023 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Comm |
|
| June 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| June 12, 2023 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2023 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Comm |
|
| June 12, 2023 |
Exhibit 99.1 Streamline Health® Reports Fiscal First Quarter 2023 Financial Results ● First quarter fiscal 2023 SaaS revenue up 12% compared to first quarter fiscal 2022 ● $17.8 million of Booked SaaS ACV as of April 30, 2023 compared to $17.2 million as of January 31, 2023; $12.7 million of Booked SaaS ACV implemented as of April 30, 2023 Atlanta, GA – June 12, 2023 – Streamline Health Solutions, |
|
| May 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defini |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defini |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| April 27, 2023 |
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Streamline Health Solutions, Inc. (the “Company,” “we,” “our,” and “us”) has authority to issue 90,000,000 shares of all classes of stock, consisting of 85,000,000 shares of Common Stock, par value $0.01 per share (the “Common Stock”), and 5,000,000 shares of Preferred St |
|
| April 27, 2023 |
Subsidiaries of Streamline Health Solutions, Inc. Exhibit 21.1 STREAMLINE HEALTH SOLUTIONS, INC. SUBSIDIARIES OF STREAMLINE HEALTH SOLUTIONS, INC. Name Jurisdiction of Incorporation % Owned Streamline Health, LLC Delaware 100 % Avelead Consulting, LLC Delaware 100 % Streamline Consulting, LLC Delaware 100 % Streamline Pay & Benefits, LLC Delaware 100 % |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| April 26, 2023 |
Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results Exhibit 99.1 FOR IMMEDIATE RELEASE Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results ● Fiscal 2022 SaaS revenue up 53% vs fiscal 2021 ● Total contract value of fiscal 2022 SaaS bookings was $22.4 million compared to $5.6 million in fiscal 2021 ● Reported $17.2 million of Booked SaaS ACV as of January 31, 2023, compared to $10.6 million as of January 31, 2022 ● E |
|
| April 26, 2023 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2023 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Com |
|
| December 29, 2022 |
Streamline Health Solutions, Inc. Investor Presentation. Exhibit 99.1 |
|
| December 29, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| December 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| December 14, 2022 |
Streamline Health® Reports Fiscal Third Quarter 2022 Financial Results Exhibit 99.1 Streamline Health? Reports Fiscal Third Quarter 2022 Financial Results ? Total contract value of SaaS bookings for the nine months ended October 31, 2022 was $14.1 million compared to $3.9 million during the same period of fiscal 2021 ? Strengthened balance sheet with recent capital raise of $8.3 million ? Third quarter 2022 SaaS revenue up 14% vs. third quarter 2021 Atlanta, GA ? Dec |
|
| December 14, 2022 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| December 5, 2022 |
Exhibit 10.1 SECOND MODIFICATION TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS SECOND MODIFICATION TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this ?Modification?) is entered into as of November 29, 2022 by and among STREAMLINE HEALTH SOLUTIONS, INC., a Delaware corporation (?Streamline?), STREAMLINE HEALTH, LLC, a Delaware limited liability company (f/k/a STREAML |
|
| December 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| November 10, 2022 |
Streamline Health Solutions, Inc. Investor Presentation. Exhibit 99.1 |
|
| November 10, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| November 1, 2022 |
STRM / Streamline Health Solutions Inc. / PESSIN NORMAN H - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Streamline Health Solutions, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 86323X106 Cusip Number Norman H. Pessin Sandra F. Pessin Brian L. Pessin 400 E 51st PH 31 New York, NY 10022 917-887-1982 (Name, Address and T |
|
| October 27, 2022 |
Streamline Health® Announces Registered Direct Offering of Common Stock Exhibit 99.1 FOR IMMEDIATE RELEASE Streamline Health? Announces Registered Direct Offering of Common Stock Atlanta, GA ? October 25, 2022 ? Streamline Health Solutions, Inc. (?Streamline? or the ?Company?) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it has entered int |
|
| October 27, 2022 |
Exhibitb 99.2 FOR IMMEDIATE RELEASE Streamline Health? Announces Strategic Alignment and Closing of Registered Direct Offering of Common Stock ? The Company closed the previously announced registered direct offering of common stock for gross proceeds of approximately $8.3 million; more than 30% was raised from insiders ? Ben Stilwill appointed President, Streamline Health Solutions, Jawad Shaikh a |
|
| October 27, 2022 |
Exhibit 10.1 COMMON STOCK PURCHASE AGREEMENT This Common Stock Purchase Agreement (this ?Agreement?) is made as of [?], 2022, by and between [?] (the ?Purchaser?), and Streamline Health Solutions, Inc., a Delaware corporation (the ?Company?). RECITALS A. Subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act of 1 |
|
| October 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (C |
|
| October 25, 2022 |
6,299,989 Shares STREAMLINE HEALTH SOLUTIONS, INC. Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-267187 PROSPECTUS SUPPLEMENT (To Prospectus dated September 13, 2022) 6,299,989 Shares STREAMLINE HEALTH SOLUTIONS, INC. Common Stock We are offering 6,299,989 shares of our common stock, par value $0.01 per share, in a registered direct offering to certain purchasers in a privately negotiated transaction pursuant to this prospectus supplement |
|
| September 9, 2022 |
Streamline Health Solutions, Inc. 2400 Old Milton Pkwy., Box 1353 Alpharetta, Georgia 30009 Streamline Health Solutions, Inc. 2400 Old Milton Pkwy., Box 1353 Alpharetta, Georgia 30009 September 9, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attn: Edwin Kim, Staff Attorney Jan Woo, Legal Branch Chief Re: Streamline Health Solutions, Inc. Registration Statement on Form S-3 Filed August 31, 2022 File |
|
| September 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| September 8, 2022 |
Exhibit 10.2 WAIVER TO LOAN AND SECURITY AGREEMENT THIS WAIVER TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this ?Waiver?), dated as of August 26, 2022, is entered into by and among STREAMLINE HEALTH SOLUTIONS, INC., a Delaware corporation (?Streamline?), STREAMLINE HEALTH, LLC, a Delaware limited liability company (f/k/a STREAMLINE HEALTH, INC., an Ohio corporation) (?Streamline He |
|
| September 7, 2022 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| September 7, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Streamline Health? Reports Fiscal Second Quarter 2022 Financial Results 109% Year-Over-Year Increase in Second Quarter Revenues to $6.0 Million; 138% SaaS Revenue Growth; $4.4 Million in New SaaS Bookings Atlanta, GA ? September 7, 2022 ? Streamline Health Solutions, Inc. (?Streamline? or the ?Company?) (Nasdaq: STRM), a leading provider of solutions that enable |
|
| August 31, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Streamline Health Solutions, Inc. |
|
| August 31, 2022 |
As filed with the Securities and Exchange Commission on August 31, 2022 As filed with the Securities and Exchange Commission on August 31, 2022 Registration Statement No. |
|
| July 6, 2022 |
Streamline Health Solutions, Inc. Investor Presentation. Exhibit 99.1 |
|
| July 6, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 6, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Commi |
|
| June 29, 2022 |
Streamline Health Solutions, Inc. 2400 Old Milton Pkwy., Box 1353 Alpharetta, Georgia 30009 CORRESP 1 filename1.htm Streamline Health Solutions, Inc. 2400 Old Milton Pkwy., Box 1353 Alpharetta, Georgia 30009 June 29, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attn: Edwin Kim, Staff Attorney Jan Woo, Legal Branch Chief Re: Streamline Health Solutions, Inc. Registration Statement on Form S-3 Filed |
|
| June 22, 2022 |
EX-FILING FEES 6 ex107.htm Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Streamline Health Solutions, Inc. (Exact Name of Each Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Of |
|
| June 22, 2022 |
As filed with the U.S. Securities and Exchange Commission on June 22, 2022 As filed with the U.S. Securities and Exchange Commission on June 22, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 31-1455414 (State or other jurisdiction of incorporation or organiza |
|
| June 22, 2022 |
As filed with the U.S. Securities and Exchange Commission on June 22, 2022 As filed with the U.S. Securities and Exchange Commission on June 22, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 31-1455414 (State or other jurisdiction of (I.R.S. Employer incorporat |
|
| June 22, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Streamline Health Solutions, Inc. |
|
| June 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| June 8, 2022 |
Exhibit 99.1 Streamline Health? Reports Fiscal First Quarter 2022 Financial Results 101% Year-Over-Year Increase in First Quarter Revenues to $5.9 Million; 141% SaaS Revenue Growth; Record $8.0 Million in New SaaS Bookings Atlanta, GA ? June 8, 2022 ? Streamline Health Solutions, Inc. (?Streamline? or the ?Company?) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers t |
|
| June 8, 2022 |
Exhibit 10.1 Amendment No. 2 to Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan This Amendment No. 2 to the Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan, as amended (this ?Amendment?) is made and entered into as of June 7, 2022 (the ?Effective Date?) by Streamline Health Solutions, Inc., a Delaware corporation (the ?C |
|
| June 8, 2022 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Commi |
|
| June 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Commi |
|
| June 8, 2022 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF STREAMLINE HEALTH SOLUTIONS, INC. STREAMLINE HEALTH SOLUTIONS, INC., a Delaware corporation (the ?Corporation?), does hereby certify that: FIRST: The name of the Corporation is STREAMLINE HEALTH SOLUTIONS, INC. SECOND: The original Certificate of Incorporation of the Corporation was filed with the Secretary of State of the Sta |
|
| June 3, 2022 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Commi |
|
| June 3, 2022 |
Exhibit 16.1 June 3, 2022 U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated June 3, 2022 of Streamline Health Solutions, Inc. and are in agreement with the statements therein concerning Dixon Hughes Goodman LLP, BKD, LLP and FORVIS, LLP. We have no basis to agree or disagree with other statements of the regi |
|
| May 9, 2022 |
DEF 14A 1 formdef14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, |
|
| April 28, 2022 |
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Streamline Health Solutions, Inc. (the ?Company,? ?we,? ?our,? and ?us?) has authority to issue 70,000,000 shares of all classes of stock, consisting of 65,000,000 shares of Common Stock, par value $0.01 per share (the ?Common Stock?), and 5,000,000 shares of Preferred St |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| April 28, 2022 |
Subsidiaries of Streamline Health Solutions, Inc. EX-21.1 3 ex21-1.htm Exhibit 21.1 STREAMLINE HEALTH SOLUTIONS, INC. SUBSIDIARIES OF STREAMLINE HEALTH SOLUTIONS, INC. Name Jurisdiction of Incorporation % Owned Streamline Health, LLC Delaware 100 % Avelead Consulting, LLC Delaware 100 % Streamline Consulting, LLC Delaware 100 % Streamline Pay & Benefits, LLC Delaware 100 % |
|
| April 27, 2022 |
Exhibit 99.1 Streamline Health? Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results Fourth Quarter Revenues of $6.0 Million; 155% SaaS Revenue Growth; $30,000 in Net Loss; ($0.3) Million in Adjusted EBITDA Atlanta, GA ? April 27, 2022 ? Streamline Health Solutions, Inc. (?Streamline? or the ?Company?) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers t |
|
| April 27, 2022 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Com |
|
| April 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission |
|
| April 14, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) Streamline Health Solutions, Inc. (Name of Issuer) Common Stock, par value $0.01 (Title of Class of Securities) 86323X106 (CUSIP Number) December 26, 2022 (Date of Event which Requi |
|
| March 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Com |
|
| February 24, 2022 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| February 24, 2022 |
Streamline Health® Announces Preliminary Fourth Quarter Bookings and Fiscal Year 2021 Revenue Exhibit 99.1 Streamline Health® Announces Preliminary Fourth Quarter Bookings and Fiscal Year 2021 Revenue Atlanta, GA – February 24, 2022 – Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced preliminary bookings r |
|
| February 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2022 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* STREAMLINE HEALTH SOLUTIONS, INC. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 86323X106 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to desi |
|
| December 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| December 8, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Streamline Health? Reports Fiscal Third Quarter 2021 Financial Results Revenues of $5.5 Million; 214% SaaS Revenue Growth; $(4.3) Million Net Loss; $(0.3) Million Adjusted EBITDA Atlanta, GA ? December 8, 2021 ? Streamline Health Solutions, Inc. (?Streamline? or the ?Company?) (Nasdaq: STRM), provider of the eValuator? Revenue Integrity Program to help healthcare |
|
| December 8, 2021 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (C |
|
| October 25, 2021 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 000-28132 31-1455414 (State or other jurisdiction |
|
| October 25, 2021 |
The accompanying notes to the financial statements are an integral part of these statements. Exhibit 99.2 AVELEAD CONSULTING, LLC UNAUDITED CONDENSED FINANCIAL STATEMENTS As of June 30, 2021 and for the Six Months Ended June 30, 2021 and 2020 AVELEAD CONSULTING, LLC TABLE OF CONTENTS UNAUDITED CONDENSED FINANCIAL STATEMENTS Balance Sheets 2 Statements of Operations 3 Statements of Members? Equity 4 Statements of Cash Flows 5 Notes to the Financial Statements 6-10 AVELEAD CONSULTING, LLC U |
|
| October 25, 2021 |
Exhibit 99.3 STREAMLINE HEALTH SOLUTIONS, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION JULY 31, 2021 BACKGROUND Streamline Health Solutions, Inc. (?we,? ?us,? ?our,? ?Streamline,? or the ?Company?), acquired all the outstanding units of Avelead Consulting, LLC (?Avelead?) a Georgia limited liability company that was subsequently converted to a Delaware limited liability compan |
|
| October 25, 2021 |
Exhibit 99.1 AVELEAD CONSULTING, LLC Financial Statements As of and for the Years Ended December 31, 2020 and 2019 And Report of Independent Auditor AVELEAD CONSULTING, LLC TABLE OF CONTENTS REPORT OF INDEPENDENT AUDITOR 1 FINANCIAL STATEMENTS Balance Sheets 2 Statements of Operations 3 Statements of Members? Equity 4 Statements of Cash Flows 5 Notes to the Financial Statements 6-13 Report of Inde |
|
| October 25, 2021 |
UNAUDITED PRO FORMA EFFECTS ON NON-GAAP FINANCIAL MEASURES Exhibit 99.4 UNAUDITED PRO FORMA EFFECTS ON NON-GAAP FINANCIAL MEASURES To provide investors with additional insight and allow for a more comprehensive understanding of the information used by management in its financial and decision-making surrounding operations, we supplement our consolidated financial statements presented on a basis consistent with U.S. generally accepted accounting principles |
|
| September 17, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 16, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) |
|
| September 17, 2021 |
Streamline Health Solutions, Inc. Investor Presentation EX-99.1 2 ex99-1.htm Exhibit 99.1 |
|
| September 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| September 8, 2021 |
STREAMLINE HEALTH SOLUTIONS, INC. CONSOLIDATED AND CONDENSED STATEMENTS OF OPERATIONS EX-99.1 2 ex99-1.htm Exhibit 99.1 Streamline Health® Reports Second Quarter 2021 Financial Results Second quarter 2021 Revenues of $2.9 million; ($0.1 million) Net Loss; ($0.8 million) Adjusted EBITDA Atlanta, GA / Wire / September 8, 2021 / Streamline Health Solutions, Inc. (NASDAQ: STRM) (“Streamline”), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively |
|
| September 8, 2021 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| September 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Co |
|
| August 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Co |
|
| August 30, 2021 |
exhibit 10.1 Streamline health solutions, inc., a Delaware corporation streamline health, inc., an Ohio corporation STREAMLINE PAY & BENEFITS, LLC, a Delaware limited liability company AVELEAD CONSULTING, LLC, a Georgia limited liability company STREAMLINE CONSULTING SOLUTIONS, LLC, a Delaware limited liability company WESTERN ALLIANCE BANK, an Arizona corporation SECOND amended and restated LOAN |
|
| August 19, 2021 |
STRM / Streamline Health Solutions Inc. / Harbert Discovery Fund, LP Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. |
|
| August 18, 2021 |
Exhibit 10.2 Execution Version RESTRICTED STOCK AGREEMENT This Restricted Stock Agreement (this ?Agreement?) is made effective as of August 16, 2021 (the ?Effective Date?), by and between Streamline Health Solutions, Inc., a Delaware corporation (the ?Company?), and Badar Shaikh an individual and resident of the State of Georgia (?Shaikh?). Unless otherwise defined herein, capitalized terms used h |
|
| August 18, 2021 |
Exhibit 10.3 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (together with Exhibits A and B attached hereto, the ?Agreement?) is entered into as of August 16, 2021 (the ?Effective Date?), by and between AVELEAD CONSULTING, LLC, a Georgia limited liability company with its headquarters at 1172 Satellite Boulevard, Suwanee, Georgia 30024 (the ?Company?), and JAWAD SHAIKH, a resident of the state of |
|
| August 18, 2021 |
Exhibit 2.1 Execution Version UNIT PURCHASE AGREEMENT BY AND AMONG streamline health solutions, inc., AVELEAD CONSULTING, LLC, JAWAD SHAIKH AND BADAR SHAIKH DATED AS OF August 16, 2021 TABLE OF CONTENTS Page Article 1 DEFINITIONS 1 Article 2 PURCHASE AND SALE 14 2.1 Purchase and Sale 14 2.2 Purchase Price; Payments by Buyer 14 2.3 Closing 15 2.4 Repaid Indebtedness 15 2.5 Purchase Price Adjustment |
|
| August 18, 2021 |
Exhibit 99.1 Streamline Health? Expands SaaS Portfolio Through Acquisition of Avelead Projected Accretive Acquisition To Expand Capabilities To Improve Healthcare Providers? Revenue Cycle Performance Atlanta, GA ? August 16, 2021? Streamline Health Solutions, Inc. (NASDAQ: STRM) (?Streamline?) provider of the eValuator? Revenue Integrity Program to help healthcare providers proactively address rev |
|
| August 18, 2021 |
Exhibit 10.1 Execution Version RESTRICTED STOCK AGREEMENT This Restricted Stock Agreement (this ?Agreement?) is made effective as of August 16, 2021 (the ?Effective Date?), by and between Streamline Health Solutions, Inc., a Delaware corporation (the ?Company?), and Jawad Shaikh an individual and resident of the State of Georgia (?Shaikh?). Unless otherwise defined herein, capitalized terms used h |
|
| August 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Co |
|
| August 4, 2021 |
As filed with the U.S. Securities and Exchange Commission on August 4, 2021 As filed with the U.S. Securities and Exchange Commission on August 4, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 31-1455414 (State or other jurisdiction of (I.R.S. Employer incorpora |
|
| August 2, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Comm |
|
| July 12, 2021 |
CORRESP 1 filename1.htm July 12, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance, Office of Technology 100 F Street, NE Washington, D.C. 20549 Attention: Katherine Wray and Jan Woo Re: Streamline Health Solutions, Inc. (the “Company”) Registration Statement on Form S-3, as Amended (File No. 333-255723) Dear Ms. Wray and Ms. Woo: In accordance with Ru |
|
| July 7, 2021 |
DEFA14A 1 formdefa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confi |
|
| July 6, 2021 |
The Company’s Definitive Proxy Statement on Schedule 14A filed on July 6, 2021; and UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Co |
|
| June 24, 2021 |
As filed with the U.S. Securities and Exchange Commission on June 23, 2021 As filed with the U.S. Securities and Exchange Commission on June 23, 2021 Registration No. 333-255723 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Pre-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 31-1455414 (State or other ju |
|
| June 23, 2021 |
Naveen Pogula (404) 504-7756 [email protected] www.mmmlaw.com June 23, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance, Office of Technology 100 F Street, NE Washington, D.C. 20549 Attention: Katherine Wray and Jan Woo Re: Streamline Health Solutions, Inc. Registration Statement on Form S-3 Filed May 3, 2021 File No. 333-255723 Dear Ms. Wray and Ms. |
|
| June 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Comm |
|
| June 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| June 8, 2021 |
STREAMLINE HEALTH SOLUTIONS, INC. CONSOLIDATED AND CONDENSED STATEMENTS OF OPERATIONS Exhibit 99.1 Streamline Health? Reports First Quarter 2021 Financial Results First quarter 2021 Revenues of $3.0 million; ($2.1 million) Net Loss; ($0.7 million) Adjusted EBITDA Atlanta, GA, June 08, 2021 (GLOBE NEWSWIRE) - Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator? Revenue Integrity Program to help healthcare providers proactively address revenue leakage and comp |
|
| June 8, 2021 |
Preliminary Proxy Statement on Schedule 14A filed with the Commission on June 8, 2021 PRE 14A 1 formpre14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [X] Preliminary Proxy Statement [ ] Confid |
|
| June 8, 2021 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Commi |
|
| May 24, 2021 |
Exhibit 10.1 Amendment No. 1 to Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan This Amendment No. 1 to the Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan (this ?Amendment?) is made and entered into as of May 24, 2021 (the ?Effective Date?) by Streamline Health Solutions, Inc., a Delaware corporation (the ?Company?). WH |
|
| May 24, 2021 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF STREAMLINE HEALTH SOLUTIONS, INC. STREAMLINE HEALTH SOLUTIONS, INC., a Delaware corporation (the ?Corporation?), does hereby certify that: FIRST: The name of the Corporation is STREAMLINE HEALTH SOLUTIONS, INC. SECOND: The original Certificate of Incorporation of the Corporation was filed with the Secretary of State of the Sta |
|
| May 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Commi |
|
| May 3, 2021 |
S-3 1 form-s3.htm As filed with the U.S. Securities and Exchange Commission on May 3, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 31-1455414 (State or other jurisdiction of incorpora |
|
| May 3, 2021 |
Exhibit 4.2 RESTRICTED STOCK AGREEMENT This Restricted Stock Agreement (this ?Agreement?) is made effective as of (the ?Effective Date?), by and between Streamline Health Solutions, Inc., a Delaware corporation (the ?Company?), and 180 Consulting, LLC, a Georgia limited liability company (?180?). Unless otherwise defined herein, capitalized terms used herein shall have the meanings ascribed to the |
|
| April 22, 2021 |
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Streamline Health Solutions, Inc. (the ?Company,? ?we,? ?our,? and ?us?) has authority to issue 50,000,000 shares of all classes of stock, consisting of 45,000,000 shares of Common Stock, par value $0.01 per share (the ?Common Stock?), and 5,000,000 shares of Preferred St |
|
| April 22, 2021 |
Definitive Proxy Statement on Schedule 14A filed with the Commission on April 22, 2021 DEF 14A 1 def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidenti |
|
| April 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| April 22, 2021 |
Subsidiaries of Streamline Health Solutions, Inc. EX-21.1 3 ex21-1.htm Exhibit 21.1 STREAMLINE HEALTH SOLUTIONS, INC. SUBSIDIARIES OF STREAMLINE HEALTH SOLUTIONS, INC. Name Jurisdiction of Incorporation % Owned Streamline Health, Inc. Ohio 100% |
|
| March 24, 2021 |
PRE 14A 1 pre14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [X] Preliminary Proxy Statement [ ] Confidenti |
|
| March 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. |
|
| March 2, 2021 |
Streamline Health Announces Pricing of Upsized $14 Million Public Offering of Common Stock Exhibit 99.2 Streamline Health Announces Pricing of Upsized $14 Million Public Offering of Common Stock Atlanta, GA ? February 26, 2021 ? Streamline Health Solutions, Inc. (NASDAQ: STRM) (?Streamline Health?), provider of the eValuator? Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance, today announced the pricing of an underwritten public of |
|
| March 2, 2021 |
Streamline Health Announces Proposed Public Offering of Common Stock Exhibit 99.1 Streamline Health Announces Proposed Public Offering of Common Stock ATLANTA, GA – February 25, 2021 – Streamline Health Solutions, Inc. (NASDAQ: STRM) (“Streamline Health” or the “Company”), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance, today announced that it intends to offer and sell shares of i |
|
| March 2, 2021 |
EX-10.1 4 ex10-1.htm Exhibit 10.1 EXECUTION VERSION Streamline health solutions, inc., a delaware corporation streamline health, inc., aN OHIO corporation WESTERN ALLIANCE BANK, an arizona corporation amended and restated LOAN AND SECURITY AGREEMENT This AMENDED AND RESTATED Loan And Security Agreement is entered into as of March 2, 2021, by and between Western Alliance Bank, an Arizona corporatio |
|
| March 2, 2021 |
Exhibit 1.1 EXECUTION VERSION 8,750,000 Shares1 Streamline Health Solutions, Inc. Common Stock, par value $0.01 per share UNDERWRITING AGREEMENT February 25, 2021 Craig-Hallum Capital Group LLC As Representative of the several Underwriters named in Schedule I hereto c/o Craig-Hallum Capital Group LLC 222 South Ninth Street, Suite 350 Minneapolis, Minnesota 55402 Ladies and Gentlemen: Streamline He |
|
| March 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2021 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) ( |
|
| March 2, 2021 |
Exhibit 99.3 Streamline Health? Expands Credit Facility with Bridge Bank Atlanta, GA ? March 1, 2021 ? Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator? Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced it has expanded its existing relationship with Bridge Bank on its credit facility. A key |
|
| February 26, 2021 |
424B5 1 form424b5.htm Filed Pursuant to Rule 424(b)(5) Registration No. 333-233727 PROSPECTUS SUPPLEMENT (To Prospectus dated September 19, 2019) 8,750,000 Shares Common Stock We are offering 8,750,000 shares of our common stock, par value $0.01 per share, as described in this prospectus supplement and the accompanying prospectus. Our common stock is listed on the Nasdaq Capital Market, or Nasdaq, |
|
| February 25, 2021 |
SUBJECT TO COMPLETION, DATED FEBRUARY 25, 2021 424B5 1 form424b5.htm Filed Pursuant to Rule 424(b)(5) Registration No. 333-233727 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has been declared effective by the Securities and Exchange Commission. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell th |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* STREAMLINE HEALTH SOLUTIONS, INC. (Name of Issuer) Common Stock, $.01 par value (Title of Class of Securities) 86323X106 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r |
|
| December 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| October 20, 2020 |
Exhibit 10.2C AMENDMENT NO. 3 STREAMLINE HEALTH SOLUTIONS, INC. 2005 INCENTIVE COMPENSATION PLAN THIS AMENDMENT NO. 3 (this “Amendment”) to the 2005 Incentive Compensation Plan, as amended (the “Plan”) of Streamline Health Solutions, Inc., a Delaware corporation (the “Company”) is made effective as of October 19, 2020. All capitalized terms not defined herein shall have the meanings provided to th |
|
| October 20, 2020 |
Other Events, Financial Statements and Exhibits - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2020 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (C |
|
| September 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| September 10, 2020 |
Exhibit 10.6 Certain identified information has been omitted from this document because it is both not material and would be competitively harmful if publicly disclosed, and had been marked with “[***]” to indicate where omissions have been made. STATEMENT OF WORK # 4 This Statement of Work (“SOW # 4”), effective as of June 8, 2020 (“Effective Date”), is made by and between Streamline Health Solut |
|
| June 11, 2020 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2020 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Comm |
|
| June 11, 2020 |
STREAMLINE HEALTH SOLUTIONS, INC. CONSOLIDATED AND CONDENSED STATEMENTS OF OPERATIONS Exhibit 99.1 Streamline Health® Reports First Quarter 2020 Financial Results First quarter 2020 revenue $2.8 million; loss from continuing operations ($1.0 million); adjusted EBITDA ($0.6 million) Atlanta, GA, June 10, 2020 (GLOBE NEWSWIRE) - Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of integrated solutions, technology-enabled services and analytics supporting revenue cycle optimi |
|
| June 11, 2020 |
Exhibit 10.6 |
|
| June 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
|
| June 3, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2020 Streamline Health Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 0-28132 31-1455414 (State or other jurisdiction of incorporation) (Commi |
|
| April 29, 2020 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2020 Streamline Health Solutions, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 0-28132 31-1455414 (State or Other Jurisdiction of Incorporation) (Com |
|
| April 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Co |
|
| April 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. |
